Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses
Cancer Currents: An NCI Cancer Research Blog,
When it comes to cancer drugs, researchers are moving away from a paradigm called the maximum tolerated dose. Instead, they’re…
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of…
Overview of attention for article published in JCO Oncology Practice, March 2024
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (97th percentile)
Readers on
- mendeley
- 18 Mendeley